Kwabanye abantu abane-MS yokubuyisela kwakhona, kuyona nto ikhethekileyo
I-Copaxone (i-acetate ye-glatiramer) isicatshulwa esichaphazela isifo sokuphulukana kwakhona-ukuyeka i-multiple-sclerosis (i-RRMS), uhlobo lwe-multiple sclerosis apho iimpawu ziza kwaye zihamba kunokuba ziqhubeke zihamba phambili. Uphando lweCopaxone luboniswe ukuba lusebenza ngokuthe ngqo ekukhuseleni ukuqhubela phambili kwe-RRMS-olungcono kunamanye unyango, enyanisweni.
Akucaci ukuba i-Copaxone igcina njani i-MS kwakhona xa kukho enye ingcamango esekelwe kwinto yokuba i-chemical composition form isfana ne-myelin sheath ejikeleze iiseli zesigulane kwaye ijolise kumphendulongwane yesistim somzimba ehlasela kwaye iyabhubhisa. Amasosha omzimba akhohliswa ekuhlaseleni amayeza endaweni ye-myelin.
Esinye isizathu sokuba iCopaxone ivele phakathi kwamayeza e-RRMS kukuba ayenziwa nge-interferon (iprotheni evimbela iintsholongwane ukuba ziphendule). Izidakamizwa ezisekelwe kwi-Interferon zineempembelelo ezithile ezenza kube lukhethi olukhethekileyo kubantu abathile. Nazi ezinye izinto ozaziyo malunga neCopaxone ukuba wena kunye nogqirha wakho nicinga ukuyongeza kwi-RIM ye-RIM.
Isikhumba soKhuseleko kunye nezinye iziphumo eziPhakathi
I-Copaxone ivela kwiisring ekhethiweyo kwaye inikezwa ngejoyiki usebenzisa inaliti emfutshane encane engeniswe ngaphantsi-ibe yincinci ye-intshi ye-2 intshi.
Iindawo ezixhaphakileyo zejoyi ziyisisu, umva wengalo, umva we-hip, umva ongentla, okanye umda wethanga. Ingcamango enhle yokujikeleza apho iphosti inikwa khona kuba inokubangela i-hunch okanye i-welts ebuhlungu esithatha iintsuku ezintlanu ukuhamba. Ezi mpendulo ze-injection-site zidla ngokunciphisa emva kweenyanga ezintathu ukuya kusetyenziswa isilwanyana.
Ukujikeleza apho iifotshane zinikezelwa kunceda ukunqanda i-lipoatrophy, ukutshatyalaliswa kweeseli ezinamafutha ezishiya uxinzelelo olusisigxina kwesikhumba kunye nezicubu eziphantsi. Uninzi lwabantu luzinikela iinjenges ngaphandle kweendawo ezinzima ukufikelela kuzo. I-Copaxone ifowuni inokugaya, kodwa nje imizuzu embalwa.
Omnye umphumo weCopaxone omele uwazi malunga nawo awunqabile kodwa uyatshwenyeka: ukuhlaselwa kwe-panic-type acute. Ezi ntshukumo zingabangela ukucubungula, intlungu yesifuba, iintlungu zentliziyo, ukuxhalaba, ukunyuka komqala kunye / okanye ukuphefumula ukuphefumla. Ezi zimpawu zenzeka kwimizuzu yesigxina, ngokugqibela malunga nemizuzu engama-15, kwaye zihamba ngokwazo. Phantse iipesenti ezili-10 zabantu abenza iCopaxone ngamava oku ncinane kanye, ngokuqhelekileyo emva kweenyanga eziliqela zokunyanga.
Ngubani ongafanele athathe iCopaxone
I-Copaxone iphephile kubantu abaninzi. Abantu kuphela abamele bangayithathi yilabo abanomdla kwi-acetate okanye i-mannitol (isiselo sotywala). Akukho ukusebenzisana okwaziwa kunye namanye amayeza.
Ukuba ukhulelwe okanye uncelisa, mhlawumbi ukhuselekile ukuba uthathe iCopaxone. Akuzange kufunyaniswe kukulimaza ekukhuleni kubantwana ekufundeni kwezilwanyana, kodwa akukho phando ekukhulelweni kwabantu, ngoko ke ukuba ulindele wena kunye nogqirha wakho kuya kufuneka ukuba uqikelele umngcipheko omncinci ngaphambi kokuqala ukuthatha iCopaxone.
Kuzo zonke izidakamizwa eziguqula izifo ze- MS, iCopaxone mhlawumbi ikhuselekile ukusetyenziswa ngexesha lokuncelisa. Ayikho idatha epapashwe, kodwa nayiphi na iCopaxone kwisibeleko se-breastmilk mhlawumbi isatshatyalaliswa kwiphepha lesisu lomntwana kunokuba lithathwe. Enye enye ingabantwana abasanda kuzalwa.
I-Copaxone ihamba ngamandla amabini: Ama-shots ama-twenty-milligram aya kukhutshwa rhoqo kunye nama-40-milligram angenayo anikwa kathathu ngeveki. I-Brand name yeCopaxone ixabisa i-$ 6,000 ukuya kwii-7,500 zamawaka ngenyanga kodwa kukho iifomu eziqhelekileyo ezithatha ukuba zixabiso elincinci. I-Copaxone kunye neefom zayo zendalo zifunyenwe yi-inshurensi yonyango kakhulu, ngoko ke ukuba iya kuba yinyango ye-MS yokhetho lonyango kufuneka unenkxalabo enokuyenza.
> Imithombo:
> Guillermo Izquierdo, uNauri Garcia-Agua Soler, uMacarena Rus, noAntonio Jose Garcia-Ruiz, "Ukuphumelela kwe-Acetate ye-Glatiramer Ukuthelekiswa namanye amayeza amaninzi e-Sclerosis." UBrain Behav . 2015 Juni; 5 (6): e00337.
> I-National Multiple Sclerosis Society. "Copaxone."
> Ulawulo lweZiko lokuTya kunye neDrug. "I-FDA iyavuma iCopyxone yokuqala ye-Generic Copexone ukuPhatha i-Multiple Sclerosis." Ngo-Apr 16, 2015.